| # | Drug | Count |
|---|---|---|
| 0 | APIXABAN | 10 |
| 1 | ALPRAZOLAM | 6 |
| 2 | FUROSEMIDE | 6 |
| 3 | BISOPROLOL FUMARATE | 5 |
| 4 | FEBUXOSTAT | 5 |
| 5 | FEBUXOSTAT TABLETS 40 MG | 5 |
| 6 | FEBUXOSTAT TABLETS 80 MG | 5 |
| 7 | LACTULOSE | 5 |
| 8 | LANSOPRAZOLE | 5 |
| 9 | RIVAROXABAN | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGUNIGALSIDASE ALFA | 1 | 0.0027 |
| 1 | ETELCALCETIDE | 2 | 0.0007 |
| 2 | FEBUXOSTAT TABLETS 40 MG | 5 | 0.0005 |
| 3 | TAFAMIDIS MEGLUMINE | 2 | 0.0004 |
| 4 | FEBUXOSTAT | 5 | 0.0003 |
| 5 | BAYER ASPIRIN EXTRA STRENGTH | 1 | 0.0003 |
| 6 | SIPULEUCEL-T | 1 | 0.0002 |
| 7 | APIXABAN | 10 | 0.0001 |
| 8 | LACTULOSE | 5 | 0.0001 |
| 9 | FOSCARBIDOPA/FOSLEVODOPA | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 14 |
| 1 | Benzodiazepine [EPC] | 6 |
| 2 | Loop Diuretic [EPC] | 6 |
| 3 | Proton Pump Inhibitor [EPC] | 6 |
| 4 | Xanthine Oxidase Inhibitor [EPC] | 6 |
| 5 | Osmotic Laxative [EPC] | 5 |
| 6 | Expectorant [EPC] | 2 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 2 |
| 9 | 5-alpha Reductase Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Autologous Cellular Immunotherapy [EPC] | 1 | 0.0002 |
| 1 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 2 | Factor Xa Inhibitor [EPC] | 14 | 0.0001 |
| 3 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 4 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | Xanthine Oxidase Inhibitor [EPC] | 6 | 0.0000 |
| 7 | Leukotriene Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Thiazide-like Diuretic [EPC] | 1 | 0.0000 |
| 9 | General Anesthetic [EPC] | 1 | 0.0000 |